Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.
1/5 보강
The process of reirradiation in oncology presents a distinctive set of challenges, wherein clinical decision-making is predicated on a delicate balancing act between the efficacy of the treatment and
APA
Zhou Y, Escande A, et al. (2025). Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 29(7-8), 104778. https://doi.org/10.1016/j.canrad.2025.104778
MLA
Zhou Y, et al.. "Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.." Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, vol. 29, no. 7-8, 2025, pp. 104778.
PMID
41289930
Abstract
The process of reirradiation in oncology presents a distinctive set of challenges, wherein clinical decision-making is predicated on a delicate balancing act between the efficacy of the treatment and the risk of severe toxicity. Despite the paucity of randomized and prospective data, an increasing number of clinical guidelines encourage its consideration for patients with local or metastatic recurrence. While awaiting dedicated guidance from international scientific societies, the following publication is based on the guidelines and multicentre reflections of the Recommendations Commission of the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology). It addresses key questions related to reirradiation, with a particular focus on prostate, gynaecological and pelvic tumours.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Characterization and Risk Factors of Folliculitis after Hair Transplantation: A Multicenter Retrospective Study.
- Botulinum Toxins for the Treatment of Raynaud Phenomenon: A Systematic Review With Meta-analysis.
- Reversing Cuproptosis Tolerance with Twinborn Metallic Polymer Nanoparticles for Enhancing Efficacy of Chemo-Immunotherapy.
- Chalcone-containing dual-targeting PD-L1/tubulin small molecules: a novel approach for cancer immunotherapy.
- Correction: Piperlongumine Inhibits Lung Cancer Growth by Inducing Endoplasmic Reticulum Stress Leading To Suppression of M2 Macrophage Polarization.